MassMutual Private Wealth & Trust’s Maravai LifeSciences MRVI Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-276	Closed	-$610	–	2445
2025 Q1	$610	Buy	+276	New	+$1.09K	﹤0.01%	2206
2024 Q3	–	Sell	-228	Closed	-$1.63K	–	2218
2024 Q2	$1.63K	Buy	+228	New	+$1.97K	﹤0.01%	1699
2024 Q1	–	Sell	-75	Closed	-$491	–	2101
2023 Q4	$491	Buy	75 +18	+32%	+$116	﹤0.01%	1821
2023 Q3	$570	Buy	+57	New	+$626	﹤0.01%	1796

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MassMutual Private Wealth & Trust's MRVI Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 276 shares — an estimated $610 sold.

MassMutual Private Wealth & Trust first reported a position in MRVI in Q3 2023 and held it in 4 quarters. The position peaked at $1.63K in Q2 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

MassMutual Private Wealth & Trust reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 276 Maravai LifeSciences shares in Q2 2025, an estimated $610.
MassMutual Private Wealth & Trust first reported a position in Maravai LifeSciences in Q3 2023 and held it in 4 quarters.
MassMutual Private Wealth & Trust's Maravai LifeSciences position peaked at $1.63K in Q2 2024.
150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.